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CrosslinkingComplex I is the only component of the eukaryotic respiratory chain of which no high-resolution
structure is yet available. A notable feature of mitochondrial complex I is the so-called active/de-
active conformational transition of the idle enzyme from the active (A) to the de-active, (D) form.
Using an amine- and sulfhydryl-reactive crosslinker of 6.8 Å length (SPDP) we found that in the D-
form of complex I the ND3 subunit crosslinked to the 39 kDa (NDUFA9) subunit. These proteins
could not be crosslinked in the A-form. Most likely, both subunits are closely located in the critical
junction region connecting the peripheral hydrophilic domain to the membrane arm of the enzyme
where the entrance path for substrate ubiquinone is and where energy transduction takes place.
Structured summary of protein interactions:
ND3 and NDUFA9 physically interact by cross-linking study (View interaction)
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction A notable feature of mitochondrial complex I is the so-called ac-Mitochondrial complex I (EC 1.6.5.3, proton-translocating
NADH:ubiquinone oxidoreductase) is responsible for oxidation of
matrix NADH by membrane-bound ubiquinone and most likely,
is also a major source of reactive oxygen species (ROS) generated
by the mitochondrial respiratory chain [1–3]. This enzyme is the
largest component of the mitochondrial and bacterial respiratory
chains [4]. Structural information about mitochondrial complex I
is still very limited, although recently the atomic structure of the
14 subunits of the prokaryotic homologue enzyme was determined
at 4.5 Å resolution [5]. Only a low resolution structure is available
for the eukaryotic enzyme [6]. Unlike the 14 subunit bacterial en-
zyme, the mammalian complex I is composed of at least 44 differ-
ent subunits and the function of more than 30 of the so-called
accessory subunits is not completely understood [7,8].tive/de-active conformational transition of the idle enzyme from
the fully competent, ‘‘active’’ (A) to the dormant, ‘‘de-activated’’
D-form. These catalytically and structurally distinct forms of the
enzyme have been identiﬁed in puriﬁed preparations in vitro, in
cells, as well as in rat heart ex vivo during lack of oxygen [9–11]
(see [12] for detailed review). Only the A-form catalyses rote-
none-sensitive oxidation of NADH with a fast rate of 104 min1.
Incubation of idle enzyme at 30–37 C results in its transition to
the D-form. In presence of NADH and ubiquinone the D-form of
complex I can be converted back to the A-form during slow
(4 min1) catalytic turnover(s). It can be seen as a lag phase during
continuous assay of the NADH-oxidase reaction catalysed by the D-
form. This lag phase represents a slow activation of the D-form of
the enzyme during the time of the measurement [10]. Several
hypotheses for the function of the D-form of complex I accumu-
lated in tissues in conditions of lack of oxygen were suggested:
prevention of proton leakage through the idle enzyme [13], ﬁne
tuning of mitochondrial activity [14,15], interaction with nitric
oxide metabolites [16], alleviating respiratory burst during reper-
fusion [17] and potential Na+/H+ antiporter activity [18].
The molecular mechanism of A/D transition is not known at
present. Sensitivity of NADH-oxidation by submitochondrial parti-
cles (SMP) to SH-reagents after incubation at 37 C was observed
many years ago [19]. Recently the thiol group exposed to the
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identiﬁed as cysteine-39 of mitochondrial ND3 subunit [20]. This is
the only known structural difference between two forms of the en-
zyme. However, the high activation energy of the A–D transition
(270 kJ/mol [9]) indicates that major conformational changes take
place during the de-activation process and, therefore, other sub-
units are most likely involved. It has been suggested that more
than one protein is involved in complex I A/D transitions in Neuros-
pora crassa complex I and 29.9 kDa protein (B13 in bovine enzyme)
may modulate the process of de-activation [21].
Here we explored subunit proximity around the cysteine-39
residue of ND3 subunit in order to gain further information on
conformational differences between two forms. Treatment of the
D-form of complex I by the amine- and sulfhydryl-reactive
heterobifunctional crosslinker N-succinimidyl 3-(2-pyridyldithio)
propionate (SPDP, length 6.8 Å) resulted in covalent binding of
ND3 to the 39 kDa (NDUFA9) subunit indicating that these
subunits are very closely located in the enzyme molecule. These
subunits could not be crosslinked in the A-form. The implications
of this ﬁnding with regard to the changes in the complex I mole-
cule upon deactivation are discussed.
2. Materials and methods
2.1. SMP and activity measurements
Bovine heart SMP were prepared according to the standard pro-
cedure [9] and stored in liquid nitrogen. In order to prepare SMP in
which complex I is present almost entirely in the D-form, an ali-
quot of frozen membranes was thawed, diluted to 5 mg/ml with
standard medium (comprising 0.25 M sucrose, 50 mM Tris–HCl
(pH 7.5), 0.2 mM EDTA) and incubated at 35 C for 1 h and
30 min. This treatment resulted in almost complete deactivation
of complex I. For complex I activation, SMP (5 mg/ml) were incu-
bated aerobically for 30 min at room temperature with 1% ethanol
and 400 lM NADH and 0.1 mg/ml alcohol dehydrogenase from
Saccharomyces cerevisiae (Sigma). During incubation with alcohol
dehydrogenase, the sub-stoichiometric amounts of NADH pro-
duced by the regeneration system were oxidized by complex I;
resulting in full activation of the enzyme. The diagnostic test for
determination of the A/D ratio at the end of the procedure, based
on the fact that in the presence of divalent cations and at alkaline
pH the rate of re-activation of complex I is very slow was per-
formed as previously described [11].
Oxidation of NADH was determined spectrophotometrically
(Varian Cary 4000) as a decrease in absorption at 340 nm (e340 -
= 6.22 mM1 cm1) with 165 lM NADH in 1 ml of standard assay
medium (0.25 M sucrose, 50 mM Tris–HCl (pH 7.5), 0.2 mM EDTA)
containing 10–50 lg protein/ml. Additional measurements of
NADH:Q1 or NADH:HAR reductase were assayed in the presence
of 1 mM cyanide with the addition of 45 lM Q1 or 1 mM HAR,
respectively (Sigma). In all inhibition studies the D-form was trea-
ted with an effector and activity was assessed only after activation
by 10 lM NADH.
2.2. SPDP crosslinker treatment
SMP containing either the A or the D complex I were diluted to
50 lg/ml with PBS (pH 8.0), 8 lM SPDP dissolved in DMF was
added and samples were incubated on ice under constant stirring.
A sample of the A-form of the enzyme treated with an equal vol-
ume of DMF was used as a control. Residual NADH-oxidase activity
was checked, every 10 min for both samples and once it reached its
ﬁnal level the reaction was stopped by adding 50 mM Tris–HCl (pH
7.0).2.3. Protein electrophoresis
Native mitochondrial respiratory complexes were separated
using Blue native gel electrophoresis in accordance to published
protocols [22]. SMP samples were solubilized by 3 mg of DDM
per mg protein as described previously [20]. Due to the formation
of large intercomplex oligomers, careful titration of SMP activity by
SPDP was performed before upscaling of labelling experiments in
order to isolate complex I by BN PAGE. The band containing com-
plex I was cut out, treated with 1% SDS and placed on top of a 10%
acrylamide gel containing 6 M urea and subjected to Tricine/SDS–
PAGE for the ﬁrst dimension. For the second dimension lane strips
of 10% gels were cut out treated with DTT (20 mM, 20 min, 40 C)
and mounted on the top of a 16% acrylamide gel. Tricine–SDS–
PAGE in the absence or in the presence of 20 mM DTT was per-
formed as described before [20,23]. Gels were stained with silver
using a mass spectrometry compatible protocol [23] or by Sypro
Ruby ﬂuorescent dye (Sigma).
2.4. Mass spectrometric analysis
The gel band was excised and cut into 1 mm cubes. These were
then subjected to in-gel digestion, using a ProGest Investigator in-
gel digestion robot (Genomic Solutions, Ann Arbor, MI) using stan-
dard protocols [24]. Brieﬂy the gel cubes were destained by wash-
ing with a 1:1 mixture of 30 mM potassium ferricyanide and
100 mM sodium thiosulphate for the silver stained bands [25]
and washing with acetonitrile for the Sypro Ruby stained bands
and subjected to DTT reduction and alkylation by iodoacetamide
before digestion with trypsin at 37 C. The peptides were extracted
with 10% formic acid and concentrated down to 20 ll using a
SpeedVac (ThermoSavant).
The peptides were then separated using a nanoLC Ultra 2D plus
loading pump and nanoLC AS2 autosampler equipped with a nano-
ﬂex cHiPLC chip-based chromatography system (Eksigent), using a
200 lm  0.5 mm ChromXP C18-CL 3 lm 120 Å trap and
75 lm  15 cm ChromXP C18-CL 3 lm 120 Å column (Eksigent).
The peptides were eluted at 300 nl/min with a gradient of increas-
ing acetonitrile, containing 0.1% formic acid (15–40% acetonitrile in
5 min, 40–95% in a further 1 min, followed by 95% acetonitrile for
3 min to clean the column, before reequilibration to 5% acetonitrile
for 10 min). The eluent was sprayed into a TripleTOF 5600 electro-
spray tandem mass spectrometer (ABSciex, Foster City, CA) ﬁtted
with a NANOSpray III ion source (ABSciex), running in positive
ion mode, and analysed in Information Dependent Acquisition
(IDA) mode, performing 250 ms of MS followed by 20  150 ms
MS/MS analyses on the 20 most intense MS peaks with charge
states +2 to +5 which exceed 150 cps. Target ions were subse-
quently excluded from analysis for 13 s. The MS ions tolerance
was set at 50 mDa. LINAC Collision Induced Dissociation (CID)
was performed with a collision energy of 45 and spread of 15 at
high sensitivity and unit resolution. The MS/MS data ﬁle generated
was analysed using the ProteinPilot Beta 4.1.46 Paragon algorithm
(ABSciex) against the UniProt/SwissProt database (accessed Nov
2011) in ‘Thorough’ mode with the ‘Biological Modiﬁcations’ ID fo-
cus speciﬁed. The search was performed with no species restric-
tion, trypsin as the cleavage enzyme and ‘Gel-Based ID’ as a
special factor. Speciﬁc, bespoke, modiﬁcation parameterizations
were created to accommodate both a SPDP [C5H8O2NS] artifact (a
covalently bound residual of crosslinking and DTT cleavage) within
ProteinPilot’s ParameterTranslation ﬁle with prior probabilities of
0.01.
All proteins were identiﬁed with >99% conﬁdence (Prot
Score > 2.0) with False Discovery Rates of: Local FDR < 5%, Global
FDR < 1%.
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mass spectrometer (Thermo) (see Supplementary information).
All chemicals were purchased from Sigma, except SPDP, which
was from ProteoChem. Protein content was determined with a
BCA assay. Data are presented as the arithmetic means ± S.D. The
experimental details are described in the legends to the ﬁgures.
3. Results
3.1. Effect of SPDP on activity of the A and the D-form of complex I
Fig. 1 demonstrates a difference in sensitivity of the A- and
D-form of complex I towards the crosslinker SPDP. This is a
heterobifunctional chemical crosslinker containing at one end
N-succinimidyl ester, which reacts with primary amines, and
2-pyridyldithio group, which reacts with cysteine thiol, at the
other end. As expected, only the D-form of the enzyme was
inhibited by the treatment since only this form is sensitive to
SH-speciﬁc reagents. The A-form was much less sensitive to
the SPDP crosslinker. The inhibitory effect was similar for
NADH-oxidase activity and NADH:Q1 reductase activity, indicat-
ing a direct effect on complex I and not on downstream compo-
nents of the respiratory chain. Addition of 50 mM Tris–HCl (pH
7.0) to stop the crosslinking followed by treatment with 2 mM
DTT, did not recover the activity of the SPDP-inhibited D-form
of the enzyme. Furthermore, the oxidation of NADH by the arti-
ﬁcial acceptor hexaammineruthenium (HAR) was not affected by
the treatment (not shown).
3.2. Identiﬁcation of crosslinked subunits
To determine if some of the complex I subunits were cross-
linked by SPDP, samples of SMP containing either the A or the D-
form of complex I were treated with the crosslinker and subjected
to Blue Native Page electrophoresis (BN-PAGE) and doubled SDS–
PAGE as in [20]. The complex I band from the BN-PAGE was excised
and subunits were separated by 10% Tricine/SDS–PAGE containing
6 M urea. Strips of the ﬁrst dimension lanes were treated with DTT
to cleave the possible crosslinked product and subunits were sep-
arated further by 16% Tricine/SDS–PAGE in the second dimension.
Therefore, subunits involved in crosslinked product formation
were expected to be found under the main diagonal and at the
same vertical.
As shown in Fig. 2, SPDP treatment resulted in the formation of
multiple crosslinked products most likely comprised of high-
molecular weight subunits of the hydrophilic domain. This is evi-
dent from the appearance of horizontal smears at the left upperFig. 1. Effect of crosslinker SPDP on NADH-oxidase (A) or NADH:Q1-reductase (B) acti
respectively). SMP (50 lg/ml) in PBS buffer (pH 8.0) incubated with 8 lM SPDP on ice. Add
Aliquots were taken during incubation and activity was assayed as described in Section 2.
and NADH:Q1 reductase reaction, respectively.side of the second dimension gel. These horizontal spears were
present in both forms of the enzyme. Two spots located exactly
at the same vertical were found only in the D-form of complex I
and not in the A-form. These were a low-molecular weight spot
1 (15 kDa) and a high-molecular weight spot 2 (40 kDa). These
spots correspond to subunits of the crosslinked product, cleaved by
DTT, which would have an apparent molecular mass of 55 kDa.
Then, we went on to identify the proteins that had been cleaved
from the crosslinked product formed speciﬁcally in the D-form of
the enzyme, by mass spectrometry. Spot 1 was positively identiﬁed
as subunit ND3 (NU3M) and spot 2 as 39 kDa subunit (NDUFA9)
(Table 1). The MS/MS spectrum of the peptide from the ND3 sub-
unit, TSPYECGFDPMGSAR, is shown in Fig. 3. This peptide has a
propionamide modiﬁcation of the cysteine, arising from the expo-
sure to acrylamide. Non-cleaved crosslinked product of these two
subunits should have an apparent molecular mass of around
55 kDa. Due to the high density of other subunits in that region
of the gel it was not possible to detect an appearance of a separate
spot for the non-cleaved product in DTT untreated samples. How-
ever, specimens excised from the region of the probable location of
the crosslinked product (spot 3) were analysed and peptides
matching to 39 kDa were found (Table 1).
3.3. Effect of protection of protein thiols by DTNB on inhibition of the
D-form of complex I by SPDP
The key cysteine residue rendering the sensitivity of the D-
form of the enzyme to SH reagent was previously determined
as Cys-39 of ND3 subunit [20]. It can be reversibly modiﬁed
by other SH-reagents such as DTNB, so that the activity of the
DTNB-inhibited enzyme can be restored by treatment with
reducing agents [26]. We investigated whether DTNB-treatment
of the D-form protects the enzyme from inhibition by SPDP by
treating the D-form with DTNB and then with a crosslinker. As
shown in Fig. 4, treatment of the D-form of complex I by DTNB
resulted in full inhibition of the enzyme. Around 75% of activity
can be restored after incubation of the DTNB-treated enzyme
with excess of DTT. The enzyme reduced by such treatment
can still be inhibited by SPDP. At the same time, treatment of
the DTNB-blocked D-form of complex I by SPDP, followed by re-
moval of the any thiol modiﬁcation by DTT, did not result in sig-
niﬁcant decrease in activity. Therefore, DTNB-treatment
protected the enzyme against irreversible inactivation by SPDP.
Most likely it indicates that both DTNB and SPDP react with
the same cysteine residue. The inhibitory effect of DTNB alone
was reversed by treatment with DTT, whereas that of SPDP alone
was not affected by the reduction by DTT (Fig. 1).vity of the A-form and the D-form of complex I in SMP (solid and empty circles,
ition of 50 mM Tris–HCl (pH 7.0) and 2 mMDTT to the D-sample is shown by arrow.
100% corresponds to 1.1 and 0.7 lmol NADHmin1 mg1 protein for NADH-oxidase
Fig. 2. Separation of the complex I crosslinked subunits by doubled SDS–PAGE. Second dimension 16% SDS–PAGE was performed using DTT-treated gel strips excised from
the lanes of the 10% acrylamide with 6 M urea SDS-gel. Representative silver-stained gels of complex I from control (A), SPDP-treated A-form (B) and SPDP-treated D-form (C)
SMP are shown. (D) Doubled SDS–PAGE of SPDP treated samples D without reduction by DTT. Two D-form speciﬁc subunits cleaved from SPDP-crosslinked product and
possible location of the crosslinked product are shown by arrows.
Table 1
Peptides, identiﬁed in the tryptic digestion of spots 1–3 obtained from the doubled SDS–PAGE of the crosslinked D-form of mitochondrial complex I.
Spota Conﬁdence (%) Sequence Modiﬁcations Cleavages Dmass (Da) Precursor (MW, Da) Precursor (m/z) Charge state (z)
1 99 TSPYECGFDPMGSAR Propionamide(C)@6 0.0002 1687.6970 844.8558 2
2 99 GKTFAFVGPSR Formyl@N-term Missed K-T@2 0.0026 1193.6167 597.8156 2
99 IPQAIAQVSK 0.0030 1053.6125 527.8149 2
99 MGSQVIVPHR 0.0042 1122.5927 562.3036 2
99 QPVYIVDVTK Gln->pyro-Glu@N-term 0.0024 1143.6152 572.8149 2
98.14 TFAFVGPSR 0.0006 980.5074 491.261 2
99 WLSSEIEDVQPAK 0.0046 1500.7415 751.378 2
3 99 IPQAIAQVSK 0.0008 1053.6125 527.8164 2
99 TVKQPVYIVDVTK Missed K-Q@3 0.0036 1488.8586 497.2923 3
a Spots were excised from the doubled SDS–PAGE of SPDP treated D-form of complex I shown on Fig. 2.
Fig. 3. MS/MS spectrum of the ND3 peptide TSPYECGFDPMGSAR obtained by nLC-ESI MSMS after tryptic digestion of spot 1 (Fig. 2).
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Fig. 4. Effect of protection of protein thiols by DTNB on inhibition of the D-form of
complex I by SPDP. SMP containing the D-form of the enzyme (1 mg/ml) were
treated by 0.2 mM DTNB for 20 min on ice and washed by centrifugation. The
sample was resuspended in PBS buffer (pH 8.0) and divided into two parts. One was
treated with 2 mM DTT and another with 8 lM SPDP for 40 min on ice. The second
sample was washed again and resuspended in the same buffer containing 5 mM
DTT to remove any thiol modiﬁcation. NADH oxidase activity was assayed at each
stage of treatment as described in Section 2. 100% corresponds to 1.1 lmol NADH
min1 mg1 protein.
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Our crosslinking studies identiﬁed the 39 kDa (NDUFA9) sub-
unit as a close neighbour of the mitochondrially encoded ND3 sub-
unit in the complex I. Polypeptides forming a crosslinked product
in the D-form were identiﬁed after resolving all enzyme subunits
ﬁrst by 10% acrylamide SDS–PAGE with urea, cleavage with DTT,
and separation in a second dimension by 16% acrylamide SDS–
PAGE electrophoresis. Two conformation speciﬁc spots observed
only in the D-form were identiﬁed as ND3 and 39 kDa. These sub-
units were crosslinked in the D-form of the enzyme and not in the
A-form, where the critical cysteine-39 of ND3 is not accessible for
modiﬁcation [20,27].
This cysteine-39 of mitochondrial ND3 subunit was recently
identiﬁed in the D-form, where it is accessible from the outside,
thus rendering the sensitivity of the D-form to SH-reagents [20].
At the same time the cysteine containing 29.9 kDa protein (B13
in bovine enzyme) was also shown to be involved in SH-reagents
sensitivity of the D-form. Therefore, the observed spot 1 could cor-
respond to subunit ND3 or B13. Tryptic digestion of subunit B13
(NDUFA5) generates detectable peptides and can be readily identi-
ﬁed by mass spectrometry (H Heide, unpublished results). How-
ever, the single tryptic peptide TSPYECGFDPMGSAR belonging to
the highly hydrophobic mitochondrially encoded subunit ND3
was identiﬁed in spot 1. As previously observed [20], due to the ex-
tremely high hydrophobicity of ND3, other peptides are unlikely to
be detected. Indeed, there are only ﬁve potential tryptic fragments
in the m/z range of 700–5000. Lower molecular weights are not
detectable and large hydrophobic peptides are non-extractable
from the 16% acrylamide gel. Therefore, the single identiﬁed pep-
tide from the hydrophilic region between the transmembrane heli-
ces is the only detectable peptide from that subunit. No peptides
from other complex I subunits or mitochondrial proteins were
found in samples from spot 1. Additional support comes from the
observation that the appearance of the low-molecular weight spot
1 was associated with a decrease in intensity of the spot corre-
sponding to ND3 subunit at the same horizontal above the main
diagonal.Most likely, SPDP reacts with a lysine amino group in the
39 kDa subunit. After DTT cleavage, the lysine side chain involved
in SPDP crosslinking would bear a 4-thiol-propanoyl group of
SPDP, which would contribute +88.1 Da of additional mass and
therefore might be expected to be detected by mass spectrometry.
The 39 kDa subunit contains 20 lysine residues and one N-termi-
nus amino group. Based on a peptide coverage obtained from spots
2 and 3 we could exclude only 8 lysines (Table 1). The rest of the
amines that potentially could be involved into cross-linking were
not detectable likely due to a number of possible reasons inherent
in in-gel digestion and nLC-ESI-MSMS procedures, thus preventing
us from identifying the exact site of modiﬁcation among those 13
candidates.
Exposure of cysteine-39 of ND3 residue is the only conforma-
tional difference between the A- and the D-forms of the enzyme
identiﬁed so far [20]. The D-form can be modiﬁed by the SH-reac-
tive DTNB and the activity of the DTNB-inhibited enzyme can be
restored by treatment with reducing agents [26]. Treatment of
the D-form of complex I by DTNB followed by removal of the thiol
blockage protected the enzyme against inactivation by SPDP.
Firstly, this indicates that both DTNB and SPDP modify the same
sulfhydryl group, namely, cysteine-39 of ND3. Secondly, taking
into account that the activity of the SPDP-modiﬁed enzyme cannot
be recovered by reduction with DTT, it is possible to conclude that
SPDP ﬁrst binds to the cysteine of ND3 and then reacts with an
amino group in the vicinity. Alternatively, the presence of the 2-ni-
tro-5-thiobenzoate group bound to the sulphur of the cysteine res-
idue could result in steric or charge-based hindrance to SPDP
binding within the local area between ND3 and the 39 kDa subunit.
Since SPDP inhibits the A-form of complex I to a lesser extent, it
means that the amino group of the 39 kDa subunit is susceptible
for modiﬁcation by SPDP only after the conformational changes
in the enzyme complex. However the magnitude of these changes
is very hard to predict, although it is unlikely, that ND3 and 39 kDa
subunits signiﬁcantly change their location within the enzyme
complex.
The 39 kDa (NDUFA9) subunit is one of the nuclear encoded
structural accessory subunits. It contains one hydrophobic seg-
ment of sufﬁcient length to form a transmembrane helix [28]. It be-
longs to the family of short-chain dehydrogenase/reductases and
contains a nucleotide binding Rossmann fold motive [29]. This sub-
unit bears a non-covalently bound NADPH [30] and most likely
plays an important role in assembly and stability of complex I
[31,32]. It was also suggested, that the 39 kDa subunit together
with the acyl carrier protein of complex I might be involved in
the synthesis of a not yet identiﬁed lipid cofactor [33]. From
assembly studies of complex I, the position of the 39 kDa subunit
is at the crucial junction region connecting the peripheral hydro-
philic domain and the membrane arm of the enzyme [34]. It corre-
sponds exactly to the location of the ND3 subunit as seen in the
structure of the enzyme from Thermus thermophilus (NqoA subunit)
[35]. This is the region where two critical events take place: en-
trance of substrate ubiquinone towards its reduction site [6,36]
and energy transduction from the redox reaction at the hydrophilic
part of the enzyme to the membrane part, where endergonic pro-
ton-translocation occurs [37,38]. It would be tempting to specu-
late, that, by changing the location of the domain of this
particular subunit, deactivation prevents the entrance of ubiqui-
none molecule through the narrow path from the membrane at
the interface between the 49 kDa and PSST subunits to the termi-
nal cluster N2 [6,35,36].
The functional role of the close association of the ND3 and
39 kDa subunits is not clear yet. Interestingly, it has been reported
that T10191C mutation in the ND3 gene (substitution of serine-34
to proline) affects the stability of the 39 kDa subunit and impairs
the formation of subcomplexes during enzyme assembly [39].
872 M. Ciano et al. / FEBS Letters 587 (2013) 867–872It is hard to say if the formation of the crosslink betweenND3 and
39 kDa in the D-form is a result of changes in the position of both
subunits or other subunits are involved in exerting or control-
lingA/D transition. Our study raises two important questions: (i)
whether or not the 39 kDa subunit is directly involved in conforma-
tional changes during A/D transition (ii) and if the association of
39 kDa and ND3 is part of the enzyme mechanism responsible for
execution of the A/D transition. The ﬁnal answer to these questions
awaits the high resolution structure of mammalian complex I.
Note added in proof
After the submission of this manuscript, an important paper on
this subject was published. In this article (Baradaran R., Berrisford
J.M., Minhas G.S., Sazanov L.A. (2013) Nature 494, 443–448) the
crystal structure of the entire, intact complex I (from Thermus ther-
mophilus) at 3.3Å resolution was reported. It was found that a crit-
ical hydrophilic loop region of the ND3 (NqoA) subunit provides a
part of the seal for the quinone binding site. Therefore, most likely,
movement of this loop upon de-activation of the mammalian en-
zyme affects interaction of the quinone headgroup with its binding
site resulting in loss of activity in the D-form.
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